PegBio Co., Ltd. (HKG:2565)
55.90
-0.10 (-0.18%)
At close: Sep 25, 2025
PegBio Statistics
Total Valuation
PegBio has a market cap or net worth of HKD 21.23 billion. The enterprise value is 20.96 billion.
Market Cap | 21.23B |
Enterprise Value | 20.96B |
Important Dates
The last earnings date was Tuesday, August 26, 2025.
Earnings Date | Aug 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PegBio has 385.96 million shares outstanding. The number of shares has decreased by -0.38% in one year.
Current Share Class | 279.16M |
Shares Outstanding | 385.96M |
Shares Change (YoY) | -0.38% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 24.53% |
Owned by Institutions (%) | 23.14% |
Float | 108.61M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 74.38 |
P/TBV Ratio | 76.11 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -86.39 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.08, with a Debt / Equity ratio of 0.32.
Current Ratio | 3.08 |
Quick Ratio | 2.99 |
Debt / Equity | 0.32 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -77.09 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -81.87% |
Revenue Per Employee | n/a |
Profits Per Employee | -4.58M |
Employee Count | 53 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 33.41 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 73.59 |
Average Volume (20 Days) | 456,709 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -242.96M |
Pretax Income | -242.75M |
Net Income | -242.62M |
EBITDA | -242.31M |
EBIT | -242.96M |
Earnings Per Share (EPS) | -0.66 |
Balance Sheet
The company has 364.58 million in cash and 92.07 million in debt, giving a net cash position of 272.51 million or 0.71 per share.
Cash & Cash Equivalents | 364.58M |
Total Debt | 92.07M |
Net Cash | 272.51M |
Net Cash Per Share | 0.71 |
Equity (Book Value) | 285.39M |
Book Value Per Share | 0.76 |
Working Capital | 255.91M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PegBio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.38% |
Shareholder Yield | n/a |
Earnings Yield | -1.14% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |